Manufacturer or GPO Program year 2025 Source: CMS Open Payments

Merck Sharp & Dohme Corporation

NJ, United States

CMS manufacturer 100000000053

Open in the dashboard

General payments

$176,852,890

1,481,141 payments

Research payments

$3,555,156,488

186,102 payments

Ownership & investment interest

$0

None reported

Through program year 2025, Merck Sharp & Dohme Corporation reported paying $176,852,890 in general payments and $3,555,156,488 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $24,391,561 197,625
2025 Research $393,808,835 5,274
2024 General $23,231,676 216,602
2024 Research $501,967,679 6,747
2023 General $23,355,830 243,910
2023 Research $544,318,366 9,080
2022 General $16,943,245 226,930
2022 Research $545,331,163 11,461
2021 General $28,234,581 213,360
2021 Research $652,465,608 11,543
2020 General $24,847,167 116,142
2020 Research $470,052,326 73,024
2019 General $35,848,830 266,572
2019 Research $447,212,511 68,973

Breakdown

Top recipients General payments · program year 2025
  1. Craig Thompson Medical Oncology · New York, NY $1,219,444 2 payments
  2. Marc Sabatine Cardiovascular Disease · Boston, MA $1,141,830 21 payments
  3. Hospital Of The Univ Of Penna Teaching hospital · PA $806,960 13 payments
  4. Montefiore Medical Center Teaching hospital · NY $551,835 8 payments
  5. Rush University Medical Center Teaching hospital · IL $494,700 9 payments
  6. Vallerie McLaughlin Cardiovascular Disease · Ann Arbor, MI $183,999 108 payments
  7. Ioana Preston Critical Care Medicine · Burlington, MA $163,080 111 payments
  8. Hyong Kim Internal Medicine · La Jolla, CA $138,080 80 payments
  9. Mardi Gomberg-Maitland Cardiovascular Disease · Washington, DC $119,245 81 payments
  10. Jay Lee Thoracic Surgery (Cardiothoracic Vascular Surgery) · Los Angeles, CA $110,553 46 payments
Top research recipients Research payments · program year 2025
  1. Ut Md Anderson Cancer Center Teaching hospital · TX $26,612,190 97 payments
  2. Memorial Sloan Kettering Cancer Center $12,435,792 73 payments
  3. Langley Porter Psychiatric Hospital Teaching hospital · CA $8,817,845 63 payments
  4. Dana-Farber Cancer Institute Teaching hospital · MA $8,320,474 31 payments
  5. Hospital Of The Univ Of Penna Teaching hospital · PA $7,333,115 49 payments
  6. Mayo Clinic $7,053,383 11 payments
  7. Memorial Sloan-Kettering Cancer Center $6,956,427 10 payments
  8. Memorial Sloan Kettering Cancer $6,780,162 8 payments
  9. Ronald Reagan Ucla Teaching hospital · CA $6,017,504 81 payments
  10. University Of Washington Med Ctr Teaching hospital · WA $5,278,198 56 payments
Products the payments named General payments · program year 2025
  1. Keytruda Oncology $3,888,756 28% · 15,861 recipients
  2. Winrevair Cardiovascular $2,244,079 16% · 3,728 recipients
  3. Capvaxive Vaccine $1,089,471 8% · 21,549 recipients
  4. Gardasil 9 Vaccine $845,731 6% · 25,348 recipients
  5. Verquvo Cardiovascular $799,273 6% · 12,303 recipients

The top 5 of 36 products; each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

The top 25 products, free in the app

Specialties paid General payments · program year 2025
  1. Medical Oncology Internal Medicine $2,937,987 14% · 1,039 practitioners
  2. Cardiovascular Disease Internal Medicine $2,611,208 12% · 3,741 practitioners
  3. Hematology & Oncology Internal Medicine $1,800,325 9% · 3,329 practitioners
  4. Pulmonary Disease Internal Medicine $1,563,291 7% · 1,827 practitioners
  5. Infectious Disease Internal Medicine $1,469,716 7% · 1,348 practitioners

The top 5 of 259 specialties; each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $3,369,057 14% · 5,578 recipients
  2. California $2,731,148 11% · 7,021 recipients
  3. Massachusetts $2,452,693 10% · 1,037 recipients
  4. Pennsylvania $2,012,091 8% · 3,198 recipients
  5. Texas $1,818,190 7% · 7,743 recipients

The top 5 of 56 states; each share is of this company’s general payments in 2025 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $79,010,916 32,677 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $36,644,710 12,880 payments
  3. Food and Beverage $27,342,557 1,384,817 payments
  4. Travel and Lodging $16,003,634 36,619 payments
  5. Grant $11,786,186 484 payments
  6. Royalty or License $3,109,179 32 payments
  7. Space rental or facility fees (teaching hospital only) $2,734,853 1,314 payments
  8. Education $220,855 12,318 payments
Companies with a similar name General payments · program years 2019–2025
  1. Merck KGaA Germany $1,615,271
  2. Merck Healthcare KGaA Germany $777,396
  3. Merck, S.L.U. Spain $8,086
  4. Merck Serono S.p.A. Italy $8,015

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent.

1,481,141 general · 186,102 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record